Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:09:44.058Z.
Calculation as of: 2026-10-06T18:09:44.058Z.
Quote observation: 2026-10-06T18:01:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d6bc5587bb9f90acc5d4b17d4ca5e7b82419962628673aeee65b4bef0dd46512
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
SciSparc Ltd.
Market Cap
$245816.00
Operating Cash Flow Yield
N/A
Market Cap
$30263.00
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| SciSparc Ltd. (SPRC) | $245816.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109567.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $384448.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96236.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72519.00 | N/A |
| Akanda Corp. (AKAN)vs › | $60871.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30263.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6191.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
